Clinical Trials
50 trialsA Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Memorial Sloan Kettering Cancer Center
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
M.D. Anderson Cancer Center
xDRIVE for Florida-based Cancer Patients
First Ascent Biomedical Inc.
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Eastern Cooperative Oncology Group
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
SISTER
University Medical Center Groningen
Digital Peer Navigation for Adolescents and Young Adults With Cancer
University Health Network, Toronto
ASSIST
Massachusetts General Hospital
HOPAYA
Centre Leon Berard
PEACE
Massachusetts General Hospital
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
University of Nebraska
Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
Dana-Farber Cancer Institute
SURGE
Colorado State University
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
Washington University School of Medicine
RGL-305+ Lymphoma + Exploratory Clinical Study
Fudan University
Virtual Rehabilitation for Cancer Survivors
University Health Network, Toronto
UPLYFT For Lymphoma Survivors
Dana-Farber Cancer Institute
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
University of Miami
CONFIRM
Brigham and Women's Hospital
Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
University of Utah
DISCOVERY
UNC Lineberger Comprehensive Cancer Center
AYA STEPS
Duke University
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Columbia University
HEM-DOAC
Medical University of Gdansk
Randomised Controlled Trial of Artificial Intelligence-assisted Health Education
Zhongnan Hospital
POSBIO-CRC
AC Camargo Cancer Center
Living Well With Lymphoma
University of Michigan Rogel Cancer Center
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
Mayo Clinic
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Memorial Sloan Kettering Cancer Center
CARTROG
University Hospital, Montpellier
Tele@home
Brno University Hospital
ALHERT
University Hospital, Angers
RESILIENCE
FundaciĆ³n Centro Nacional de Investigaciones Cardiovasculares Carlos III
HEME Home Transfusion Program
Dana-Farber Cancer Institute
ACT
Rigshospitalet, Denmark
PROACTIVE
University of Nebraska
Mosaic
Northwestern University
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
UNC Lineberger Comprehensive Cancer Center
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
Hebei Senlang Biotechnology Inc., Ltd.
BIOLYMPH2020
Centre Hospitalier Universitaire Dijon
CARTIER
FundaciĆ³n Instituto de Estudios de Ciencias de la Salud de Castilla y LeĆ³n
DeLPHy
Hospices Civils de Lyon
CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
Shanxi Bethune Hospital
Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
Biogipuzkoa Health Research Institute
ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma
University Hospital Muenster
PALS_CT
Alberta Health Services, Calgary
LYMfit
Norwegian School of Sport Sciences
Integrative Medicine in Lymphoma Survivors
Bnai Zion Medical Center
Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL
Hebei Senlang Biotechnology Inc., Ltd.
CD7 CAR-T Cells in T-cell Lymphoma/Leukemia
Shenzhen University General Hospital